SKI Market

Indian Indices

Nifty

26,175.75 -27.20
(-0.10%)

Sensex

85,641.90 -64.77
( -0.08%)

Bank Nifty

59,681.35 -71.35
( -0.12%)

Nifty IT

37,549.75 144.25
( 0.39%)

Global Indices

Nasdaq

47,737.43 289.30
(0.61%)

Dow Jones

6,869.48 35.87
(0.52%)

Hang Seng

49,313.21 -940.70
(-1.87%)

Nikkei 225

9,721.02 27.09
(0.28%)

Forex

USD-INR

89.30 0.10
(0.11%)

EUR-INR

103.54 0.22
(0.21%)

GBP-INR

118.23 0.49
(0.41%)

JPY-INR

0.57 0.00
(0.17%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Andrew Yule & Company Ltd

Industry : Diversified - Medium / Small

BSE Code

ISIN Demat

Book Value()

526173

INE449C01025

2.5735585

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ANDREWYU

1203.31

EPS(TTM)

Face Value()

Div & Yield %

Back

aravali securities & finance ltd

Dr Reddy's Laboratories consolidated net profit rises 7.28% in the September 2025 quarter

Oct 25,2025

Net profit of Dr Reddy's Laboratories rose 7.28% to Rs 1347.10 crore in the quarter ended September 2025 as against Rs 1255.70 crore during the previous quarter ended September 2024. Sales rose 9.84% to Rs 8804.90 crore in the quarter ended September 2025 as against Rs 8016.10 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	8804.90	8016.10	10
OPM %	22.83	25.90	-
PBDT	2249.40	2314.40	-3
PBT	1744.80	1917.40	-9
NP	1347.10	1255.70	7

26,175.75 -27.20 (-0.10%)

85,641.90 -64.77 ( -0.08%)

59,681.35 -71.35 ( -0.12%)

37,549.75 144.25 ( 0.39%)

47,737.43 289.30 (0.61%)

6,869.48 35.87 (0.52%)

49,313.21 -940.70 (-1.87%)

9,721.02 27.09 (0.28%)

89.30 0.10 (0.11%)

103.54 0.22 (0.21%)

118.23 0.49 (0.41%)

0.57 0.00 (0.17%)